Historique
Article de Périodique
Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy (2018)
Auteur(s) :
K. BIRD ;
M. E. SOCIAS ;
L. TI
Article en page(s) :
1-2
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Résumé :
As new, more tolerable and effective hepatitis C virus (HCV) treatments are available, there is a global need to consider how to maximize treatment access for groups who are most affected by HCV. A substantial number of people who inject drugs (PWID) are living with HCV, yet only a minority have received treatment. HCV treatment programs that are integrated into community-based addiction care may be a successful way to overcome barriers and increase access and uptake of HCV treatment for this population. Examples of successful HCV and addiction care integration in the community have been documented. However, potential challenges to integration exist and include changing healthcare provider roles, lack of stimulant use research and restrictive drug policies. Successful engagement of PWID in HCV care is critical step towards the elimination of HCV infection. Further research and efforts are needed in order to reach this goal.
Affiliation :
Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada